tiprankstipranks
Needham upgrades BioCryst to Buy, sees selloff provide attractive entry
The Fly

Needham upgrades BioCryst to Buy, sees selloff provide attractive entry

Needham upgraded BioCryst to Buy from Hold with a $14 price target. The stock has come under significant pressure following the company’s Q4 earnings update and a setback with the early-stage BCX10013 program., but the sell-off also provides an "attractive entry opportunity", the analyst tells investors in a research note. The firm adds that the sell-off was likely overdone and that BioCryst’s 25% year-to-date decline brought its shares to level that fails to adequately capture Orladeyo’s sales and growth trajectory.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on BCRX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles